Pregled bibliografske jedinice broj: 902955
The NDE1 genomic locus can affect treatment of psychiatric illness through gene expression cahnges related to microRNA-484
The NDE1 genomic locus can affect treatment of psychiatric illness through gene expression cahnges related to microRNA-484 // Open Biology, 7 (2017), 170153-170153 doi:10.1098/rsob.170153 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 902955 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The NDE1 genomic locus can affect treatment of psychiatric illness through gene expression cahnges related to microRNA-484
Autori
Bradshaw, Nicholas J. ; Ukkola-Vuoti, Liisa ; Pankakoski, Maiju ; Zheutlin, Amanda B. ; Ortega-Olonso, Alfredo ; Torniainen-Holm, Minna ; Sinha, Vishal ; Therman, Sebastien ; Paunio, Tiina ; Suvisaari, Jaana ; Lönnqvist, Jouko ; Cannon, Tyrone D ; Haukka, Jari ; Hennah, William
Izvornik
Open Biology (2046-2441) 7
(2017);
170153-170153
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
schizophrenia ; gene expression ; DISC1 network ; NDE1 ; miR-484 ; pharmacogenetics
Sažetak
Genetic studies of familial schizophrenia in Finland have observed significant associations with a group of biologically related genes, DISC1, NDE1, NDEL1, PDE4B and PDE4D, the ‘DISC1 network’. Here, we use gene expression and psychoactive medication use data to study their biological consequences and potential treatment implications. Gene expression levels were determined in 64 individuals from 18 families, while prescription medication information has been collected over a 10-year period for 931 affected individuals. We demonstrate that the NDE1 SNP rs2242549 associates with significant changes in gene expression for 2908 probes (2542 genes), of which 794 probes (719 genes) were replicable. A significant number of the genes altered were predicted targets of microRNA-484 ( p ¼ 3.0 1028), located on a non-coding exon of NDE1. Variants within the NDE1 locus also displayed significant genotype by gender interaction to early cessation of psychoactive medications metabolized by CYP2C19. Furthermore, we demonstrate that miR-484 can affect the expression of CYP2C19 in a cell culture system. Thus, variation at the NDE1 locus may alter risk of mental illness, in part through modification of miR-484, and such modification alters treatment response to specific psychoactive medications, leading to the potential for use of this locus in targeting treatment.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Sveučilište u Rijeci - Odjel za biotehnologiju
Profili:
Nicholas James Bradshaw
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE